- Chemimage Corporation Company News Section

Chemimage Corporation Press Release -

  • Hyperspectral Imaging Shows Promise In Solving Diagnostic Dilemmas In Pathology
  • Raman molecular imaging (RMI), a form of hyperspectral imaging, shows promise in identifying cancers that are typically difficult to diagnose. Its history, successes and current advancements will be discussed at the International Conference on Raman Spectroscopy (ICORS), Aug. 13 from 8:30 - 10:00 a.m. at the Boston Park Plaza Hotel in Boston.
  • August 06, 2010